Fat emulsion infusion potentiates coagulation activation during human endotoxemia

Thrombosis and Haemostasis

Volumn 75, Issue 1, 1996, Pages 83-86

  Van Der Poll, Tom ^a   Coyle, Susette M ^b   Levi, Marcel ^b   Boermeester, Marja A ^b   Braxton, Carla C ^b   Jansen, Patty M ^b   Hack, C Erik ^b   Lowry, Stephen F ^b  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ANTIPLASMIN; ANTITHROMBIN III; INTRALIPID; LIPID EMULSION; PLASMIN; PLASMINOGEN ACTIVATOR INHIBITOR; PROTHROMBIN; THROMBIN; TISSUE PLASMINOGEN ACTIVATOR;

ADULT; ARTICLE; BLOOD CLOTTING; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOTOXEMIA; FIBRINOLYSIS; HUMAN; HUMAN EXPERIMENT; INFECTIOUS COMPLICATION; INTRAVENOUS DRUG ADMINISTRATION; MALE; MALNUTRITION; NORMAL HUMAN; PRIORITY JOURNAL; THROMBOSIS;

EID: 0030052673     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0038-1650225     Document Type: Article

References (42)

1. Seidner DL, Mascioli EA, Istfan NW, Porter KA, Selleck K, Blackburn GL, Bistrian BR. Effects of long-chain triglyceride emulsions on reticuloendothelial system function in humans. J Parent Ent Nutr 1989; 13: 614-9.
2. Robin AP, Arain I, Phuangsap A, Holian O, Roccaforte P, Barrett JA. Intravenous fat emulsion acutely suppresses neutrophil chemiluminescence. J Parent Ent Nutr 1989; 13: 608-13.
3. Strunk RC, Kunke KS, Kolski GB, Revsin BK. Intralipid alters macrophage membrane fatty acid composition and inhibits complement (C2) synthesis. Lipids 1983; 18: 493-500.
4. Gogos CA, Kalfarentzos FE, Zoumbos NC. Effect of different types of TPN on T lymphocyte subpopulatious and NK cells. Am J Clin Nutr 1990; 51: 119-22.
5. Freeman J, Goldmann DA, Smith NE, Siddebottom DG, Epstein MF, Platt R. Association of intravenous lipid emulsion and coagulase-negative staphylococcal bacteremia in neonatal intensive care units. N Engl J Med 1990; 323: 301-8.
6. Levi M, ten Cate H, van der Poll T, van Deventer SJH. Pathogenesis of disseminated intravascular coagulation in sepsis. JAMA 1993; 270: 975-9.
7. Montemurro P, Lattanzio A, Chetta G, Lupo L, Caputi-Iambrenghi L, Rubino M, Giordano D, Semeraro N. Increased in vitro and in vivo generation of procoagulant activity (tissue factor) by mononuclear phagocytes after Intralipid infusion in rabbits. Blood 1985; 65: 1391-5.
8. Lattanzio A, Montemurro P, Pannarale O, Altomare DF, Palasciano N, de Rinaldis P, Semeraro N. Increased production of coagulant activity (tissue factor) by human peripheral blood monocytes after Intralipid infusion. Clin Nutr 1984; 3: 177-81.
9. Wakefield A, Cohen Z, Craig M, Connolley P, Jeejeebhoy KN, Silverman R, Levy GA. Thrombogenicity of total parenteral nutrition solutions: I. Effect on induction of monocyte/macrophage procoagulant activity. Gastroenterology 1989; 97: 1210-9.
10. Wakefield A, Cohen Z, Rosenthal A, Craig M, Jeejeebhoy KN, Gotlieb A, Levy GA. Thrombogenicity of total parenteral nutrition solutions: II. Effect on induction of endothelial cell procoagulant activity. Gastroenterology 1989; 97: 1220-8.
11. Altomare DF, Semeraro N, Colucci M. Reduction of the plasma levels of tissue plasminogen activator after infusion of a lipid emulsion in humans. J Parent Ent Nutr 1993; 17: 274-6.
12. Van der Poll T, Lowry SF. Biological responses to endotoxin in humans. In: Modulation of the Inflammatory Response in Severe Sepsis. Tellado JM, Forse RA, Solomkin JS (eds). Basel, Karger AG 1995; pp 18-32.
13. van Zonneveld AJ, Veerman H, Brakenhoff JPJ, Aarden LA, Cajot JF, Pannekoek H. Mapping of epitopes on human tissue-type plasminogen activator with recombinant deletion mutant proteins. Thromb Haemost 1987; 57: 82-6.
14. De Boer JP, Abbink JJ, Brouwer MC, Meijer C, Roem D, Voorn GP, Lambers JWJ, van Mourik JA, Hack CE PAI-1 synthesis in the human hepatoma cell line Hep G2 is increased by cytokines. Evidence that the liver contributes to acute phase behaviour of PAI-1. Thromb Haemost 1991; 65: 181-5.
15. De Boer JP, Creasy AA, Chang A, Roem D, Brouwer MC, Eerenberg AJM, Hack CE, Taylor Jr FB. Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal dose of Escherichia coli. Circ Shock 1993; 39: 59-67.
16. Levi M, ten Cate H, Bauer KA, van der Poll T, Edgington TS, Büller HR, van Deventer SJH, Hack CE, ten Cate JW, Rosenberg RD. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees. J Clin Invest 1994; 93: 114-20.
17. Buzby TP. Perioperative nutritional support. J Parent Ent Nutr 1990; 14 (suppl): 197-9S.
18. Maynard ND, Bihari DJ. Postoperative feeding. Time to rehabilitate the gut. BMJ 1991; 303: 1007-8.
19. van Deventer SJH, Büller HR, ten Cate JW, Aarden LA, Hack CE, Sturk A. Experimental endotoxemia in humans: analysis of cytokine release and coagulation, fibrinolytic and complement pathways. Blood 1990; 76: 2520-6.
20. Biemond BJ, ten Cate H, Levi M, Soule HR, Morris LD, Foster DL, Bogowitz CA, van der Poll T, Büller HR, ten Cate JW. Complete inhibition of endotoxin-induced coagulation activation in chimpanzees with a monoclonal Fab fragment against factor VII/VIIa. Thromb Haemost 1995; 73: 223-30.
21. Schlichting E, Henriksen T, Lyberg T. Lipoproteins do not modulate the tissue factor activity, plasminogen activator or tumour necrosis factor production induced by lipopolysaccharide stimulation of human monocytes. Scand J Clin Lab Invest 1994; 54:465-73.
22. Carvalho de Sousa J, Bruckert E, Giral P, Soria C, Chapman J, Truffert J, Dairou F, de Gennes JL, Caen JP. Coagulation factor VII and plasma triglycerides: decreased catabolism as a possible mechanism of factor VII hyperactivity. Haemostas 1989; 19: 125-30.
23. Carvalho de Sousa J, Soria C, Ayrault-Jarrier M, Pastier D, Bruckert E, Amiral J, Bereziat G, Caen JP. Association between coagulation factors VlI and X with triglyceride-rich lipoproteins. J Clin Pathol 1988; 41: 940-4.
24. Hallberg D, Wersall J. The electron-microscopic investigation of chylomicrons and fat emulsions for intravenous use. Acta Chir Scand Suppl 1964; 325: 23-5.
25. Hallberg D. Studies on the elimination of exogenous lipids from the blood stream. Acta Physiol Scand 1964; 62: 407-10.
26. Boberg J, Carlson LA. Determination of heparin-induced lipoprotein lipase activity in human plasma. Clin Chim Acta 1964; 10:420-7.
27. Erkelens DW, Brunzell JD, Bierman EL. Availability of apolipoprotein CII in relation to the maximal removal capacity for an infused triglyceride emulsion in man. Metabolism 1979; 28: 495-501.
28. Robinson D, Quardfordt S. Apoproteins in association with Intralipid incubations in rat and human plasma. Lipids 1979; 14: 343-9.
29. Granot E, Deckelbaum RJ, Eisenberg S, Oschry Y, Bengtsson-Olivecrona G. Core modification of human low-density lipoprotein by artificial triacyl-glycerol emulsion. Biochim Biophys Acta 1985; 833: 308-15.
30. Huth K, Schoenborn W, Knorpp K. Experimentelle Verbrauchskoagulopathie nach intravenöser Zufuhr von Fett und Endotoxin. Thrombos Diathes Haemorrh 1967; 17: 129-43.
31. Lo SK, Cheung A, Zheng Q, Silverstein RL. Induction of tissue factor on monocytes by adhesion to endothelial cells. J Immunol 1995; 154: 4768-77.
32. Suffredini AF, Harpel PC, Parrillo JE. Promotion and subsequent inhibition of plasminogen activation after administration of intravenous endotoxin to normal subjects. N Engl J Med 1989, 320: 1165-72.
33. Haglund O, Wibell L, Saldeen T. Plasminogen activators and inhibitors of plasminogen activators in patients with deep venous thrombosis (DVT). Diurnal variation of the inhibitor. Thromb Haemost 1985; 54: 271-9.
34. Hamsten A, Wiman B, de Faire U, Blombäck M. Increased plasma levels of a rapid inhibitor of tissue plasminogen activator in young survivors of myocardial infarction. N Engl J Med 1985; 313: 1557-63.
35. Mehta J, Mehta P, Lawson D, Saldeen T. Plasma tissue plasminogen activator inhibitor levels in coronary artery disease: correlation with age and serum triglyceride concentrations. J Am Coll Cardiol 1987; 9: 263-8.
36. Chakrabarti R, Hocking ED, Fearnley GR, Mann RD, Attwell TN, Jackson D. Fibrinolytic activity and coronary artery disease. Lancet 1986; i: 987-90.
37. Falk E. Coronary thrombosis: pathogenesis and clinical manifestations. Am J Cardiol 1991; 68: 28B-35B.
38. Report of a meeting of physicians and scientists, University College London Medical School. Hypertnglyceridaemia and vascular risk. Lancet 1993; 342: 781-7.
39. Drake TA, Morrisey JH, Edgington TS. Selective cellular expression of tissue factor in human tissues. Implications for disorders of hemostasis and thrombosis. Am J Pathol 1989; 134: 1087-97.
40. Brismar B, Härdstedt C, Malmborg AS. Bacteriology and phlebography in catheterization for parenteral nutrition. Acta Chir Scand 1980; 146: 115-9.
41. Brismar B, Härdstedt C, Jacobsen S. Diagnosis of thrombosis by catheter phlebography after prolonged central venous catheterization. Arch Surg 1981; 194: 779-84.
42. Burt ME, Dunnick NR, Drudy AG, Mather MM, Brennan MF. Prospective evaluation of subclavian vein thrombosis during total parenteral nutrition by contrast venography. Clin Res 1981; 20: 246A